Kymera | Investor Day Presentation Deck | 105 slides · page 55 of 105
The diagram illustrates a multi-arm clinical trial design with dose escalation (DL1, DL2, DLx) leading to MTD/RP2D expansion cohorts for various indications, including combination therapy arms.
Conference presentation · other · present_framework · balanced density
Slide locked Sign in to view
Slide schematic 3/3
diagram 1/1 list 1/1 title 1/1
Components 3
process bullet headline
Tools 0
∅
No tools
No canon tool match is anchored to this slide.
Metrics 0
∅
No metrics
No metric insight is anchored to this slide.
Frameworks 1